Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not

Figures & data

Figure 1. Meningococcal disease dynamics among adolescents and young adults by college attendance status, and immunization delivery.

(a) Number of IMD cases in US individuals 18–24 years of age by college attendance status during 2015–2017. Data are from Enhanced Meningococcal Disease Surveillance Reports 2015–2017 (available at: https://www.cdc.gov/meningococcal/surveillance/index.html#enhanced-reports) [3]. (b) Serogroup distribution of IMD cases by college attendance status during 2015–2017. Data are from Enhanced Meningococcal Disease Surveillance Reports 2015–2017 [3]. (c) 2018 immunization rates of US adolescents 13–17 years of age for various vaccines. Data are from Walker et al. MMWR Morb Mortal Wkly Rep. 2019;68:718–723 [10]. (d) MenACWY and MenB vaccination status of IMD cases in US individuals 18–24 years of age with known vaccination history by college attendance status in 2015–2017. Data are from Enhanced Meningococcal Disease Surveillance Reports 2015–2017 [3]. HPV = human papillomavirus vaccine; IMD = invasive meningococcal disease; MenACWY = meningococcal serogroups A, C, W, and Y vaccine; MenB = meningococcal serogroup B vaccine; Tdap = tetanus, diphtheria, and acellular pertussis vaccine.^aIn adolescents 17 years of age.

Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance reports 2015–2017 [Internet]. [cited 2018 Dec 4]. Available from: https://www.cdc.gov/meningococcal/surveillance/index.html#enhanced-reports

 Google Scholar

Walker TY, Elam-Evans LD, Yankey D, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(33):718–723.

 PubMed Web of Science ®Google Scholar